Holen Sie sich die Stockscreener-App
6.02
0.50%
-0.03
Handel nachbörslich:
5.91
-0.11
-1.83%
Finanzdaten der Reshape Lifesciences Inc-Aktie (RSLS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
1.92%
1.944
|
1.982 | 2.155 | 2.254 | 2.287 |
| Cost Of Revenue |
456.43%
0.779
|
0.14 | 0.867 | 1.06 | 1.063 |
| Gross Profit |
36.75%
1.165
|
1.842 | 1.288 | 1.194 | 1.224 |
Operating Expenses
|
9.69%
3.375
|
3.737 | 5.168 | 5.17 | 6.855 |
| Benefits Costs and Expenses |
12.99%
4.123
|
3.649 | 5.686 | 5.743 | 4.935 |
| Costs And Expenses |
12.99%
4.123
|
3.649 | 5.686 | 5.743 | 4.935 |
| Operating Income/Loss |
16.62%
-2.21
|
-1.895 | -3.88 | -3.976 | -5.631 |
| Income/Loss From Continuing Operations Before Tax |
30.71%
-2.179
|
-1.667 | -3.531 | -3.489 | -2.648 |
| Income Tax Expense/Benefit, Deferred |
96.30%
0.001
|
0.027 | 0.002 | - | -0.001 |
| Income Tax Expense/Benefit |
54.84%
0.014
|
0.031 | 0.003 | 0.004 | 0.014 |
| Income/Loss From Continuing Operations After Tax |
29.15%
-2.193
|
-1.698 | -3.534 | -3.493 | -2.662 |
|
Net Income/Loss
|
29.15%
-2.193
|
-1.698 | -3.534 | -3.493 | -2.662 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
645.43%
23.46
|
3.1468 | 3.4527 | 3.2493 | 1.7081 |
| Diluted Average Shares |
645.43%
23.46
|
3.1468 | 3.4527 | 3.2493 | 1.7081 |
| Basic Earnings Per Share |
105.84%
-0.09
|
1.54 | -1.02 | -1.08 | -1.56 |
| Diluted Earnings Per Share |
105.84%
-0.09
|
1.54 | -1.02 | -1.08 | -1.56 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.47%
1.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):